摘要
目的观察普米克令舒联合博利康尼氧气作动力雾化吸入治疗毛细支气管炎的疗效。方法将本院治疗的毛细支气管炎患儿从2008年1月至2012年3月共250例随机分为特殊治疗组与一般治疗组,特殊治疗组的125例患儿在常规治疗的基础上再加以普米克令舒联合博利康尼氧驱雾化吸入;一般治疗组125例仅进行常规治疗。结果特殊治疗组的患儿的住院天数及症状、体征消失时间全部优于一般治疗组(P<0.05),总有效率特殊治疗组的90.4%,一般治疗组的70.4%,治疗效果两组差异有统计学意义(P<0.05)。结论毛细支气管炎是一种下呼吸道感染性疾病,属儿科危急疾病,发病于2岁以下婴幼儿,呼吸道合胞病毒是主要的致病病毒,病变部位主要在毛细支气管,毛细支气管容易发生阻塞,阻塞原因如:分泌物、黏膜水肿、平滑肌痉挛。小儿毛细支气管炎用普米克令舒联合博利康尼雾化吸入治疗疗效有保证,有临床推广使用的价值。
Objective Of Pulmicort and Bricanyl oxygen atomizing inhalation on bronchiolitis.Methods children with bronchiolitis were treated in our hospital from 2008 January to 2012 March a total of 250 patients were randomly divided into the treatment group and the special general treatment group,125 cases of children with special treatment group and Pulmicort and Bricanyl oxygen nebulizer inhalation on the basis of conventional treatment; general treatment group 125 cases only routine treatment.Results The special group of hospitalization days and symptoms,signs disappeared time were superior to conventional treatment group（P 0.05）,the total efficiency of treatment group 90.4% ,general treatment group 70.4% ,the difference was statistically significant therapeutic effect of two groups（P 0.05）.Conclusion Capillary bronchitis is an infective respiratory disease,pediatric critical illness belongs,incidence in infants under 2 years old,respiratory syncytial virus is the virus that causes the main,lesions mainly in capillary bronchi,bronchial capillary prone to congestion,congestion reasons such as： secretion,mucosal edema,muscle spasm.Bronchiolitis in children with Pulmicort and Bricanyl aerosol inhalation treatment to ensure the curative effect,the clinical application value.
出处
《中国现代药物应用》
2013年第11期27-28,共2页
Chinese Journal of Modern Drug Application
